Figure 2. Dose–response curve for the B16F10 cell line at 72 h of treatment with different concentrations of gemcitabine (Gem; A), and cisplatin (Cis; B) alone, in combination, and with 50% cytotoxic concentration (CC50) doses of short hairpin RNA against Wilm’s tumor gene (shRNA-WT1).